Panbela Therapeutics SMA 50
What is the SMA 50 of Panbela Therapeutics?
The SMA 50 of Panbela Therapeutics Inc. is $0 -11.64%
What is the definition of SMA 50?
SMA 50 is an average stock price from the last 50 days calculated as an unweighted mean of the previous 50 stock closing prices.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 of companies in the Health Care sector on NASDAQ compared to Panbela Therapeutics
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Companies with sma 50 similar to Panbela Therapeutics
- Greenstone Capital has SMA 50 of CAD$0 -500.00%
- Mastrad Société Anonyme has SMA 50 of $0 +0.61%
- Applied Genetic Technologies Corp has SMA 50 of $0 +0.00%
- Pacifico Minerals has SMA 50 of AUD$0 +99.70%
- Dxi Capital Corp has SMA 50 of $0 +98.70%
- Summa Silver has SMA 50 of CAD$0 -10.05%
- Panbela Therapeutics has SMA 50 of $0 -11.64%
- Elate has SMA 50 of HKD$0 +11.10%
- QUHUO Ltd has SMA 50 of $0 +76.29%
- Doubleview Gold Corp has SMA 50 of CAD$0 -4.34%
- Changmao Biochemical Engineering has SMA 50 of HKD$0 +14.81%
- Artini has SMA 50 of HKD$0 -7.49%
- Beijing Media has SMA 50 of HKD$0 -2.01%